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Abstract
Understanding the molecular link between diet and health is a key goal in nutritional systems biology. As an alternative to
pathway analysis, we have developed a joint multivariate and network-based approach to analysis of a dataset of habitual
dietary records, adipose tissue transcriptomics and comprehensive plasma marker profiles from human volunteers with the
Metabolic Syndrome. With this approach we identified prominent co-expressed sub-networks in the global metabolic
network, which showed correlated expression with habitual n-3 PUFA intake and urinary levels of the oxidative stress
marker 8-iso-PGF2a. These sub-networks illustrated inherent cross-talk between distinct metabolic pathways, such as
between triglyceride metabolism and production of lipid signalling molecules. In a parallel promoter analysis, we identified
several adipogenic transcription factors as potential transcriptional regulators associated with habitual n-3 PUFA intake. Our
results illustrate advantages of network-based analysis, and generate novel hypotheses on the transcriptomic link between
habitual n-3 PUFA intake, adipose tissue function and oxidative stress.
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Introduction
Dietary fat intake has profound effects on molecular processes of
metabolic health. These effects are diverse and often subtle,
representing a considerable analytical challenge in reaching system-
level understanding. Transcriptomics has become a central technol-
ogy in the development of molecular nutrition, having the capacity to
produce expression data for every gene in a given genome. However,
the major challenge is to apply appropriate techniques for extracting
information from high-throughput datasets. Differentially expressed
gene lists are an intuitive first choice, but they are hard to interpret in
a biological context. Pathway analysis – typically implemented using
gene set enrichment analysis – has become a standard method in the
field of transcriptomic analysis [1,2]. It is easy to implement and can
simplify and contextualize large lists of differentially expressed genes,
although this approach possesses technical limitations due to inherent
redundancy among pathways and interconnectedness between one
pathway and the next. Failure to appropriately account for these
features can substantially limit biological interpretation of high-
throughput datasets.
Network-level analysis has revealed detailed insight on
metabolic regulation in type 2 diabetes and insulin resistance
[3,4]. Del Sol et al., have proposed that in the emerging systems-
level view of molecular biology, diseases should be viewed as a
function of network perturbation rather than as isolated local
changes [5]. Molecular networks may be classified in two
categories: metabolic networks and protein interaction networks.
Metabolic networks are inclusive, intuitive abstractions for
representing system-level metabolism, as they incorporate all
known metabolic interactions in a given species. Due to their size
and complexity, however, they are analytically challenging.
Previously applied analytical approaches include topological
analysis (e.g., identification of hub nodes and functional modules)
[6] and reporter metabolite analysis [4].
A number of methods exist for analyzing transcriptomic data in
the context of a global interaction network [7]. The majority of
these methods focus on protein interaction networks, and aim to
partition a global network into clusters/modules of genes, and
identify clusters showing coordinated transcriptomic response.
When modelling transcriptomic activity in metabolic networks,
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constructs, because paths match the native pattern of energy flux
through a metabolic network. Cluster-based analysis of metabolic
network activity performs well in identifying regions of a network
with altered transcriptomic activity, but the identified clusters may
contain disconnected sections of different paths of metabolite
conversion. A given path of interest may thus be fractioned across
several different neighbouring clusters, making it difficult to
identify coordinated alteration of activity across that entire path.
We therefore defined a method that identifies altered transcrip-
tomic activity in the context of network paths rather than clusters.
With this approach, we identified local coexpressed paths in the
metabolic network showing covariance with recorded dietary
intake of n-3 PUFA, and correlation with a urinary marker of
oxidative stress. In a parallel analysis, investigation of the promoter
regions of n-3 PUFA-correlated genes highlighted significantly
over-represented binding sites for transcription factors related to
adipogenesis.
Materials and Methods
Ethics statement
The LIPGENE human dietary intervention study was a
randomized, controlled trial that complied with the 1983 Helsinki
Declarations, approved by the local ethics committees of the 8
intervention centres (Dublin, Ireland; Reading, UK; Oslo, Nor-
way; Marseille, France; Maastricht, The Netherlands; Cordoba,
Spain; Krakow, Poland; Uppsala, Sweden). Written informed
consent was attained from every participant as approved by each
institutional ethical committee.
Study design
The current study was conducted within the framework of the
LIPGENE Integrated Project ‘‘Diet, genomics and the metabolic
syndrome: an integrated nutrition, agro-food, social and economic
analysis’’ (Clinical Trials. gov number: NCT00429195) and
NuGO, The Nutrigenomics Organization (www.nugo.org); both
European Union FP 6 initiatives. The subjects participated in the
LIPGENE human dietary intervention study [8], although only
baseline, pre-intervention samples were used in the present study.
Samples were collected under standardised conditions according
to a strict SOP [9]. Briefly, volunteers attended the clinics
following a 12 h overnight fast; they were asked to abstain from
alcohol, medications or vigorous exercise in the 24 h prior to
assessment. For inclusion in the study, volunteers were required to
be age 35–70 years, BMI 20–40 kg/m
3 and show 3 or more of the
following MetS criteria (based on slightly modified NCEP ATP-
III): fasting plasma glucose 5.5–7.8 mmol/L, serum TAG
$1.5 mmol/L, serum HDL-cholesterol ,1.0 mmol/L in males,
and ,1.3 mmol/L in females, waist circumference .102 cm in
males and .88 cm in females, and elevated blood pressure
(systolic blood pressure $130 mmHg, diastolic blood pressure
$85 mmHg or on prescribed blood pressure lowering medica-
tion). Habitual dietary intake was monitored for each volunteer by
a 3 day weighed food dietary record, and assessed for daily intake
of energy, carbohydrate, protein, fat, saturated fat (SFA),
monounsaturated fat (MUFA), polyunsaturated fat (PUFA), and
n-3 and n-6 PUFA [10]. Extensive metabolic profiling including
plasma markers of inflammation, fatty acid pattern, plasma
lipoproteins and apolipoprotein profiles, and markers of insulin
sensitivity (Table 1), was performed as described by Tierney et al.
[9]. Means and standard deviations for all dietary and plasma
marker variables in our cohort are provided in supplementary
Tables S1 and S2.
Adipose tissue biopsy collection, RNA extraction and
microarray hybridization
Subcutaneous adipose tissue samples were taken from the
periumbilical area of 19 volunteers from the Norwegian and
Spanish cohorts (10 female, 9 male) after an overnight fast. Needle
biopsies were obtained after a 5 mm transdermal incision under
local anaesthesia. Samples were rinsed in saline, put in RNA later
and frozen immediately (280uC) for subsequent analysis. Total
RNA was extracted from adipose tissue using the RNeasy lipid
tissue mini kit (Qiagen, U.K.). Briefly, 100 mg of adipose tissue
was homogenised in Qiazol lysis reagent. After addition of
chloroform, the homogenate was centrifuged to separate the
aqueous and organic phases. Ethanol was added to the upper
aqueous phase, and applied to the RNeasy spin column, where the
total RNA was bound to the membrane, and phenol and other
contaminants were washed away. RNA was then eluted in RNase-
free water.
Extracted RNA was sent to ServiceXS (a high-throughput data
service provider; www.servicexs.com) for labelling with the 3’ IVT
express kit and hybridization to Affymetrix arrays. The microarray
platform used in this study was custom designed by NuGO, and
contained 16554 probe sets. This platform is designated
‘nugohs1a520180’, and we used the ‘entrezg’ version 12.1.0
annotation from the MBNI custom cdf database, reflecting the
latest remapping of Affymetrix probes based on current data in the
NCBI database (http://brainarray.mbni.med.umich.edu). Raw
and GCRMA-normalized data are available from the Gene
Expression Omnibus database, under accession GSE28070.
Microarray QC and pre-processing
Raw microarray data were first assessed for quality using a set of
standard QC tests, including array intensity distribution, positive
and negative border element distribution, GAPDH and b-actin
3’/5’ ratios, centre of intensity and array-array correlation check.
All QC tests were implemented in the R programming language
(Version 2.11.1l, R Foundation for Statistical Computing), using
the affyQCReport library. A batch effect was noted due to the
arrays being hybridized on two separate days; thus, all subsequent
analyses accounted for this effect by including batch number as a
covariate in statistical models. It was also noted that the b-actin 3’/
5’ ratios were higher than recommended (i.e., greater than 3-fold
intensity difference) in most samples, although this ratio has been
Author Summary
A fundamental goal in the field of nutritional genomics is
defining the molecular link between diet and health.
Human nutritional genomic studies are frequently hin-
dered by a high level of unexplained variation in gene
expression, protein and metabolite abundance, and clinical
parameters – potentially attributable to variation in
genotype, background diet, anthropometry, physical
activity and health status. In our present study, relation-
ships between adipose tissue gene expression, habitual
diet and clinical markers of metabolic health were
investigated in a cohort of individuals with impaired
metabolic health, typical of the Metabolic Syndrome
(MetS). Using multivariate statistics in conjunction with a
novel approach to metabolic network analysis, we
identified regions of the human metabolic network
showing coordinated transcriptomic response to variation
in n-3 PUFA intake and correlation with markers of
metabolic health.
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3’ IVT express kit, particularly with low input RNA quantities
(http://media.affymetrix.com/support/technical/whitepapers/3_
ivtexpresskit_whitepaper.pdf). Furthermore, all samples except 2
showed 3’/5’ GAPDH ratios within expected range of 1.25-fold,
and no samples appeared suspect in RNA degradation plots. The
2 samples that did not meet the GAPDH ratio recommendation
were removed from further analysis. All QC-verified samples were
background corrected and normalized using the GCRMA
normalization method, which accounts for nucleotide specific
differences in hybridization efficiency. The normalized dataset
was then filtered to remove genes with Mas5 ‘absent’ call on all
arrays, and those showing the lowest 10% variance, resulting in a
final dataset of 10618 genes.
Statistical analysis of diet-gene and clinical marker-gene
associations
Diet and plasma marker variables were first normalized with log
or square root transformation as appropriate to reduce skewness
and kurtosis. Sparse partial least squares regression (sPLS; [11])
and regularized canonical correlation analysis (rCCA; [12]) were
used to assess relationships between dietary components and gene
expression levels, and between clinical markers and gene
expression levels, respectively. The mixOmics library of R
functions was used to carry out the analysis [12]. Specifically,
the spls function was used to fit the sPLS model, and the network
function to produce the network of interactions. An sPLS model
was fitted using dietary variables, sex, nationality and array batch
number as predictors (sex, nationality and array batch number
were included in order to identify and control for correlations
between gene expression and these variables), and gene expression
as response variables. Choice of PLS dimensions was determined
using the Qh
2 variable previously proposed by Tenenhaus [13]
which measures the relative contribution of each dimension h to
the predictive power of the PLS model (see 11 and 13 for further
details on sPLS and use of Qh
2). With this approach, we retained 5
dimensions in the model, and retained all diet-gene pairs showing
a similarity score .0.7 (using ‘threshold’ argument of the network
function in the mixOmics library). This similarity score is a
convention used in multivariate statistical methods; it ranges from
0 to 1, and corresponds to the distance between two given
variables in the number of chosen dimensions [14].
The mixOmics library was used for rCCA modelling of plasma
marker and gene expression data. The rcc function was used to
define the canonical correlations and the canonical variates,
estim.regul for estimation of regularization parameters and the
network function to produce the network of interactions. In this
case, datasets were not interpreted as predictors or responses given
the more complex two-way relationship between plasma marker
profile and tissue gene expression. Initial rCCA modelling
including all plasma markers showed that correlations between
gene expression and plasma fatty acid and lipid profile were so
strong that they masked more subtle correlations between the
remaining plasma markers and expression data. Consequently,
separate rCCA analyses were performed: first, comparing adipose
tissue gene expression to plasma fatty acids, lipids and apolipo-
protein profile (including sex, nationality and array batch number
as variables in the model); and second, comparing gene expression
to plasma cytokines, IVGTT measurements, prostaglandin and
urinary isoprostane (as before, including sex, nationality and array
batch number as variables in the model). For comparison of gene
expression vs. plasma fatty acids, lipids and apolipoproteins, the
first 11 dimensions were retained in the model (as subsequent
dimensions did not provide additional information to the model)
and all gene-plasma marker pairs with a similarity score .0.75
were retained for subsequent analysis. Due to the very strong
relationship between gene expression and plasma fatty acids, we
observed that using a similarity score threshold of 0.7 resulted in a
very high number of plasma marker-gene correlations (571 plasma
marker-gene pairs passing threshold). Therefore, the higher
threshold was chosen in this comparison in order to highlight
only the strongest plasma marker-gene correlations, thereby
Table 1. Plasma markers measured in the LIPGENE study.
Fatty acid profile Lipids Apolipoproteins IVGTT Inflammatory markers
C14:0 Triglycerides ApoA1 Glucose AUC* C-Reactive protein
C16: Cholesterol ApoB IL-6
C16:1 NEFA ApoCII TNFa
C18:0 TRL-TG ApoCIII sICAM
C18:1 TRL-C ApoE sVCAM
C18:2 n-6 LDL-C TRL Apo B Resistin
C18:3 n-6 T-HDL Adiponectin
C18:4 n-3 PAI-1
C20:1 tPA
C20:3 n-6 Fibrinogen
C20:4 n-6 Leptin
C20:4 n-3 8-iso-PGF2a (urinary)
C20:5 n-3 15-keto-PGF2a (plasma)
C22: 4 n-6
C22:5 n-3
C22:6 n-3
*Derived from relative area under the curve (AUC) of plasma glucose measurements (mmol/L) at 12 time points from 0 to 180 minutes following intravenous glucose
challenge.
doi:10.1371/journal.pcbi.1002223.t001
Habitual Diet, Transcriptome and Metabolic Health
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comparison (gene expression vs plasma cytokines, IVGTT
measurements, prostaglandin and urinary isoprostane) the first 6
dimensions and all gene-plasma marker pairs with a similarity
score .0.7, were retained in the model.
Metabolic network analysis
We used the Edinburgh human metabolic network reconstruc-
tion [15]; (www.ehmn.bioinformatics.ed.ac.uk/), which contains
reaction information for 1627 unique metabolites and 1371
unique metabolic enzymes. In its native form, this reconstruction is
a metabolite-centred network (i.e., nodes represent metabolites and
edges are the enzymes that catalyze reactions between metabo-
lites). For our analysis, the network was first transformed to an
enzyme-centric construction (where 2 genes/proteins are linked if
gene 1 produces a metabolite that is used as a metabolic substrate
by gene 2). As is the norm in topology-based network analyses, we
excluded currency metabolites (such as H2O, ATP and O2) from
the network [16].
Assessment of gene-gene coexpression in the human
metabolic network. Coexpression was assessed for each
gene-gene pair in the metabolic network reconstruction using
Akaike’s information criterion (AIC), a criterion used to select an
optimal model among competing possibilities [17]. As our network
construction contains directionality information, coexpression
between two genes could be assessed using a linear model of
gene 2 expression as a function of gene 1 expression. In our human
sample, however, we would expect the variables sex and nationality
to be related to expression of some (but not all) genes in the
dataset. The AIC approach allows selection of the optimal model
among all possible combinations of predictor variables, thus
including additional variables only where appropriate. The exact
value of AIC is determined by
AIC~2k{2ln L ðÞ
where k refers to the number of parameters in the statistical model,
and L is the maximized likelihood value for the fitted model. An
optimal model will have high likelihood while being parsimonious;
thus, lower AIC values indicate a better model. As each gene pair
in the network possesses directionality information (i.e., gene 1
produces a compound that is metabolized by gene 2), expression
level of gene 2 can be estimated as a function of gene 1 expression
plus additional factors, batch, sex and nationality:
Y~b0zXb1zbb2zsb3znb4ze
where Y and X represent expression of gene 2 and 1, respectively;
b, s and n represent batch, sex and nationality; b0, b1, b2, b3 and b4
represent the intercept and partial regression coefficients for each
variable; and e represents random error. We would expect a batch
effect to be present across the entire platform; thus, this variable
was included in all models. The AIC values were calculated for
models containing b plus all possible combinations of the
additional factors (X, s and n); gene 1 and gene 2 were
considered to be coexpressed if gene 1 expression was present as
a predictor variable in the optimal model.
Extraction of diet-sensitive paths from the
transcriptionally coordinated network
To identify paths of interest in the global interaction network,
Dijkstra’sshortestpaths [18] were calculated from each diet-sensitive
node to all others in the coexpressed subset of the global network (as
determined above), taking into consideration directionality of node
pair interactions. An algorithm was written in R to evaluate
metabolic feasibility of eachputative path – i.e. whether an unbroken
path of metabolite conversion could be traced from one end to
another (most recent scripts available on request). This concept of
metabolic feasibility is an important consideration in analysis of
globalnetworks,because a connectedpaththroughthe networkdoes
not necessarily indicate an unbroken path of metabolite conversion.
Figure 1 illustrates the rationale behind metabolic feasibility (see
supplementary Figure S1 for detailed description of the algorithm).
The output of this algorithm is a list of feasible paths of metabolite
conversion, wherein each path is strongly coexpressed (i.e., between
eachgene pairinthe path)and possessesa diet-correlatedgene at the
upstream end. To our knowledge, this is the first metabolic network
analysis algorithm that explicitly considers metabolic feasibility and
Figure 1. Assessing metabolic feasibility in network paths. The algorithm of network analysis in this study includes a two-step process: 1)
extraction of connected paths from the node of interest to all others in the network; and 2) evaluation of metabolic feasibility of each candidate path.
Given a candidate (i.e., connected) path in the network through genes [ARBRCRD], the goal of the second step of the algorithm is to determine if a
path of metabolite conversion can be traced from the first node to the last. In this simplified example, although a connectivity path can be traced
from A to D, metabolite conversion cannot, emphasizing the importance of assessing metabolic feasibility in putative paths. A feasible path can only
be traced from [ZRBRCRD] through conversion of metabolites [C3RC4RC5].
doi:10.1371/journal.pcbi.1002223.g001
Habitual Diet, Transcriptome and Metabolic Health
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represents an informative alternative to network clustering analysis.
Promoter analysis
The TFM-explorer tool [19] was used to identify significantly
over-represented transcription factor binding sites (TFBSs) among
genes with expression showing positive correlation with n-3-PUFA
intake. Using the promoter regions spanning -2000+200 bp
relative to the transcription start site and all vertebrate
transcription factor matrices from the Jaspar database (jaspar.cgb.-
ki.se), TFM-explorer returned all TFBSs that were significantly
over-represented at a level of p,0.0001.
Results
Multivariate analysis identifies a strong relationship
between dietary n-3 PUFA, adipose tissue gene
expression and markers of metabolic health
Results from sPLS indicated that among all dietary variables,
the registered dietary intake of n-3-PUFA showed the strongest
covariance with adipose tissue gene expression. Of the 53 n-3-
PUFA-correlated genes identified in the sPLS analysis, 41
positively correlated and 12 negatively correlated with n-3-PUFA
intake (Figure 2; Supplementary Table S3). Dietary intake of
MUFA also showed strong covariance with expression of three of
these genes (one positive: GALNTL1; two negative: CDIPT,
PRPS1). It was also noted that the expression level of these three
genes covaried in opposing direction with intake of n-3-PUFA and
MUFA, reflecting the inverse relationship between habitual
dietary consumption of these two dietary fatty acids in our
population. To assess if .=53 n-3 PUFA-correlated genes would
be detected by chance alone, we permuted the sample labels and
re-ran the sPLS analysis 100 times. These permutation tests
yielded an average of 2.38 and median of 0 n-3 PUFA-correlated
genes, suggesting that the 53 genes identified in our original
dataset were unlikely to be identified by chance alone.
rCCA results showed that among the measured plasma lipids,
fatty acids and apolipoproteins, plasma DHA, stearic acid and
EPA correlated most strongly with adipose tissue gene expression
(Figure 2; Supplementary Table S4). At the chosen threshold of
0.75, DHA [C22:6 n-3] correlated with the expression of 113
genes, followed by plasma stearic acid [C18:0]: 60 genes, and EPA
[C20:5 n-3]: 21 genes. Comparison of sPLS and rCCA results
highlighted 26 genes that were related to dietary n-3-PUFA intake
as well as plasma DHA levels, reflecting the expected correlation
between dietary fat intake and plasma fatty acid profile [20].
Among markers of inflammation, oxidative stress and insulin
resistance, urinary 8-iso-PGF2a correlated most strongly with
adipose gene expression, resulting in 96 gene correlations, 48 of
which also correlated with plasma DHA (Figure 2; Supplementary
Table S5). Any variables not included in Figure 2 (e.g., IVGTT)
did not correlate with any adipose tissue genes at the chosen
threshold.
Thecompletemetabolicnetworkincluded1371nodesand 65637
directed edges; the transcriptionally coexpressed (TC) subset
contained 602 nodes and 5414 directed edges (supplementary
Figure S2). To identify the biological functions predominant in this
network, the largest connected subset of the TC subset network was
partitioned into topological modules using a simulated annealing
approach [21], as implemented by the spinglass.community function in
the igraph library in R. This modular partitioning identified 3
topological modules. Hypergeometric tests were performed using
the Category library in R to identify significantly over-represented
Figure 2. Network of associations between dietary intake, adipose gene expression, and phenotypic markers, determined by sPLS
and rCCA. Green nodes: dietary variables; yellow: lipid, fatty acid and apolipoprotein variables; red: inflammatory and oxidative stress markers; blue:
genes (enzymes). Solid lines: positive correlation (rCCA)/covariance (sPLS); dashed lines: negative correlation/covariance.
doi:10.1371/journal.pcbi.1002223.g002
Habitual Diet, Transcriptome and Metabolic Health
PLoS Computational Biology | www.ploscompbiol.org 5 November 2011 | Volume 7 | Issue 11 | e1002223gene ontology (www.geneontology.org) ‘biological process’ terms in
each module. Briefly, over-represented terms in the first module
related primarily to phosphatidylinositol and lipid metabolism;
those in second related to nucleic acid metabolism; and the third
module was more heterogeneous, consisting of cellular ketone
metabolism, red-ox processes, and lipid and protein catabolism
terms (see supplementary Table S6 for expanded results).
Coexpressed paths in the metabolic network related to
n-3 PUFA intake
Diet-sensitive path extraction from the TC network revealed
755 unique paths greater than length 2 originating from 30 n-3
PUFA-sensitive genes, although paths leading from each diet-
sensitive gene collapsed into tree-like structures (Figure 3). The
most complex n-3 PUFA-sensitive path (in terms of path size and
link density) centred on the AK1 gene (Figure 3A). The genes in the
AK1 path are mostly involved in the highly redundant processes of
energy and nucleotide metabolism, explaining the high link density
in this region of the network. The majority of metabolic links in
the AK1 path are different nucleotides and energy metabolism
cofactors such as ATP, ADP and AMP. These metabolites are
normally classified as currency metabolites and were removed
from the rest of the network, although they were retained in this
region where they act as primary reactants and products. Of the
nodes in this path, an additional 7 correlated with dietary intake of
n-3 PUFA, 28 strongly correlated with plasma fatty acid levels,
and 14 with urinary 8-iso-PGF2a, suggesting that activity in this
region of the metabolic network is sensitive to dietary intake of n-3
PUFA and correlated with metabolic health.
The ANXA3, PTEN and MTMR12-linked paths (Figure 3B-D)
are interesting from a biological perspective because they each
incorporate elements of lipid metabolism. The ANXA3-linked path
primarily includes reactions involved in metabolism of glyceroli-
pids, glycerophospholipids, arachidonic acid (AA) and linoleic acid
(LA). ANXA3 is connected to ADH5 and LPL via the glycerol
metabolite, which is further metabolized by LIPA and DGKA to
form 1,2-diacyl-sn-glycerol (1,2-diacylglycerol) and phosphatidate
on one branch of the path, and by ALDH isoforms to form d-
glyceraldehyde and d-glycerate on the other. Five genes in this
path correlated strongly with plasma levels of DHA, stearic acid,
dihomo-gamma-linolenic acid and/or EPA.
The PTEN-linked path includes reactions that metabolize
inositol phosphate- and lipid-related metabolites. PTEN is linked
to OXSM and PLCL2 via the 1-phosphatidyl-D-myo-inositol 4,5-
bisphosphate, which is metabolized by these enzymes to form 1-
phosphatidyl-myo-inositol 5-phosphate and 1,2-diacyl-sn-glycer-
ol. This 1,2-diacyl-sn-glycerol is further metabolized by DGKA to
form phosphatidate. Two genes in this path – PTEN and OXSM –
were inversely correlated with urinary 8-iso-PGF2a,a n dt h r e e–
PLCL2, DGKA and CDS2 – were positively correlated with plasma
DHA level.
The MTMR12 path (Figure 3D) is also linked to lipid
metabolism via phosphatidylcholine, through a more complex
upstream path involving inositol phosphate derivatives. At the
downstream end of this path, cytochrome p450 enzymes
(MYP19A1, CYP2B6 and CYP1B1) act on AA and LA as
substrates to form diverse epoxyeicosatrienoic acids (EET),
hydroxyeicosatrienoic acids (HETE) and epoxyoctadecenoic
acids (EpOME), involved in the resolution of inflammation with
subsequent relevance to cardiovascular disease [22,23]. Two
genes in this path – PIK3CAand PIP5K1A – were negatively
correlated with urinary 8-iso-PGF2a; PIKFYVE, PIK3CA, and
CEPT1 were positively correlated with plasma DHA, and
PIP5K1A with plasma stearic acid and dihomo-gamma-linolenic
acid.
To assess whether a similar group of paths would be extracted
from any TC network – e.g., due to higher connectivity in certain
regions of the network – we generated such a TC network from
publicly available muscle tissue microarray data from obese
individuals (GEO accession: GSE474), and extracted paths leading
from the n-3 PUFA-sensitive genes identified in the present study.
In this muscle tissue TC network we found only 24 paths of
maximum length three leading from ten of the n-3-PUFA-sensitive
genes (supplementary Table S7). Furthermore, these paths did not
intersect to form a larger sub-network.
To compare our network analysis with a standard approach to
pathway analysis, hypergeometric tests were performed to identify
KEGG pathways significantly enriched (using the hyperGTest
function in the R ‘Category’ library) for the n-3PUFA-sensitive
genes identified in our sPLS analysis. This analysis returned four
KEGG pathways greater than length four (Table 2). Of these
pathways, the top three - biosynthesis of plant hormones,
biosynthesis of terpenoids and steroids and biosynthesis of
alkaloids derived from terpenoid and polyketide - have 45 genes
in common. Accordingly, the same 7 n-3 PUFA-sensitive genes
(PMVK, FDFT1, ALDOA, IDH3G, PGK1, SDHB, GGPS1) were
present in each pathway. Thus, the apparent enrichment of the
biosynthetic plant hormones pathway is probably an artifact of the
high degree of overlap with other pathways in the database. Closer
inspection of these pathways in the KEGG database showed that
they are large, diverse and disjointed pathways, including many
parallel processes. For example, the pathway for biosynthesis of
terpenoids and steroids includes of subsets of glycolysis, limonene
and pinene degradation, terpenoid backbone biosynthesis, carot-
enoid biosynthesis and geraniol degradation. The n-3 PUFA-
correlated genes were distributed across these processes rather
than occurring in a single one.
Promoter analysis highlights over-represented
adipogenic transcription factors among n-3 PUFA-
correlated genes
Figure 4 illustrates over-represented TFBSs among genes
showing positive correlation with the intake of n-3 PUFA (from
our sPLS results). The three most significantly over-represented
TFBSs were those of Kru ¨ppel-like factor 4 (KLF4), specificity
protein 1 (SP1) and E2F1 transcription factors. KLF4 is involved
in adipogenesis, specifically by binding to the promoter of the
CEBPB (C/EBPb) gene [24]. CEBPB was not present in the
Edinburgh human metabolic network (as it is not a metabolic
enzyme). Thus, an expanded sPLS analysis was performed,
comparing dietary intake to all genes on the Affymetrix
microarray. This analysis identified CEBPB expression to be
positively correlated with n-3 PUFA intake (data not shown).
Although no additional adipogenic genes were identified at this
correlation threshold of 0.7, reducing the threshold to 0.6 revealed
a number of additional adipogenic factors showing positive
correlation with n-3 PUFA intake – including ADIPOQ, BMP2,
CFD, FABP4, LIPE, LPL and PLIN.
SP1 is a broadly acting transcription factor operating in
conjunction with NF-YA, SREBP and PPARc in promoting
lipogenesis. The NF-YA and PPARc TFBSs were also significantly
over-represented in our group of n-3 PUFA-sensitive genes,
although SREBP TFBS was not. E2F1 is a transcription factor
involved in early adipogenesis, and positively regulates transcrip-
tion of PPARc [25]. Interestingly, all but one PPARc TFBS-
containing genes in our sample also contained an E2F1 TFBS.
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An emerging limitation to pathway analysis of transcriptomic
data is that documented pathway models tend to overlap and
intersect, yielding analytical results that are biased, incomplete or
both [26]. Our network approach did not segregate metabolic
processes into discrete pathway models, thereby revealing inherent
overlaps and intersections between pathways. Examples of this
pattern are seen in the ANXA3, PTEN and MTMR12 paths, which
incorporate connected reactions from the metabolic pathways of
inositol phosphate derivatives, glycerolipids, glycerophospholipids,
arachidonic and linoleic acid. Intersections of these pathways are
clear when viewed in the network context, but less evident when
each canonical pathway is assessed separately. Cross-talk between
metabolism of lipids/fatty acids and inositol phosphate derivatives
plays an important role in the induction of signalling cascades by
dietary and fat [27]. Figure 3B-D illustrates paths of triglyceride
metabolism including formation of intermediate metabolites such
as diacylglycerol and phosphatidate. These metabolites act as
signalling molecules that affect a wide range of cellular functions
like insulin signalling, inflammation, cellular differentiation and
proliferation and oxidative stress [28,29]. Thus, it is of particular
interest that genes in the PTEN and MTMR12 paths show strong
inverse correlation with urinary 8-iso-PGF2a – a marker of
systemic oxidative stress.
Previous work has described an inverse relationship between n-3
PUFA intake and n-6 fatty acid-derived prostaglandins (e.g.,
PGF2a) in the plasma of Alzheimer’s disease patients [30], urine of
healthy males [31] and plasma and urine of dyslipidaemic and
type 2 diabetic individuals [32]. A prevalent hypothesis for this
relationship is that n-3 and n-6 PUFA compete for the same
enzyme systems, and consequently, increased n-3 PUFA intake
precludes production of n-6 fatty acid-derived prostaglandins [33].
In addition, n-3 PUFA may exert independent anti-inflammatory
effects through unique receptors and enzyme systems, regardless of
n-6 fatty acid intake [34]. Our analysis identified 17 genes showing
opposing direction of correlation with n-3 PUFA intake and
urinary 8-iso-PGF2a (Figure 2). Furthermore, results from network
analysis identified precise coexpressed regions of the metabolic
network showing positive correlation with dietary n-3 PUFA
intake and plasma DHA, and negative correlation with urinary 8-
iso-PGF2a in the cohort of MetS subjects (Figure 3). The sub-
network illustrated in Figure 3A is interesting in this context
because it contains numerous members of the electron transport
chain, including 20 isoforms of ATPase/ATP synthase, six of
which were negatively correlated with 8-iso-PGF2a. Further
investigation of diet-dependent energy flux through these network
regions may provide insight on the precise relationship between n-
3 PUFA intake and adipose tissue oxidative stress. Comparing n-3
PUFA intake directly to urinary 8-iso-PGF2a resulted in only a
near-significant trend (p=0.077; p=0.0828 after adjusting for
sex); a recent publication of findings from the larger LIPGENE
cohort reported a similar near-significant trend [35]. This may be
due to the number of molecular intermediates between dietary
intake and urinary output, highlighting the increased clarity
provided by analysis of tissue-level high throughput data in the
framework of a global metabolic network.
To understand the potential regulatory consequences of dietary
n-3 PUFA intake on adipose tissue biology, we analysed the
promoter regions of n-3 PUFA-correlated genes to identify
significantly over-represented transcription factor binding sites.
Results from this analysis highlighted significantly over-represent-
ed transcription factors related to adipogenesis. The most strongly
over-represented transcription factors were KLF4, SP1 and E2F1.
SP1 and KLF4 share similar GC-rich target binding sites [36],
which is evident in their overlapping binding sites in Figure 4.
Although limited work has focused on joint activity of these
transcription factors in adipose tissue, KLF4 has been shown to
inhibit SP1 activity in the gut by competitive TFBS binding [37].
PPARc was also identified as significantly over-represented among
genes correlated with habitual n-3 PUFA intake. PPARc is
arguably the most well-studied transcription factor in the field of
diet-related transcriptomic regulation, and is the subject of many
reviews on the subject [38,39,40,41]. In addition to its role as a
central regulator of adipogenesis, lipid storage and combustion,
PPARc also protects against oxidative stress and inflammation
[42]. Dietary n-3 PUFA are potent inducers of PPARc expression
in adipocytes [43] and preadipocytes [44]. Accordingly, n-3 PUFA
supplementation has yielded positive effects on weight gain in
cancer [45] and Alzheimer’s patients [46], and reduced lipotoxi-
city in a range of experimental models [47]. Future work should
clarify the contribution of these adipogenic transcription factors to
adipose tissue function, particularly given the positive correlation
in our present study between dietary n-3 PUFA intake and
expression of additional adipogenic genes, including CEBPB,
ADIPOQ, BMP2, CFD, FABP4, LIPE, LPL and PLIN1.
In conclusion, we have taken a joint multivariate and network-
based approach to transcriptomic analysis, relying on known
metabolic reaction information to reveal coordinated paths of
metabolite conversion. This approach highlighted coexpressed
regions of the metabolic network with opposing direction of
correlation with habitual n-3 PUFA intake and urinary isoprotane
Figure 3. Transcriptionally coordinated paths leading from genes correlated with habitual n-3 PUFA intake. Green nodes: dietary
variables; yellow: lipid, fatty acid and apolipoprotein variables; red: inflammatory and oxidative stress markers; blue: genes (enzymes). Dashed lines
indicate negative correlation. A: Path linked to AK1; B: Detailed path linked to ANXA3; C: Detailed path linked to PTEN; D: Detailed path linked to
MTMR12.
doi:10.1371/journal.pcbi.1002223.g003
Table 2. KEGG pathways differentially regulated by n-3 PUFA intake using a hypergeometric test.
Term Expected count Observed count Pathway size P value
Biosynthesis of plant hormones 3.607 9 60 0.007
Biosynthesis of terpenoids and steroids 2.886 7 48 0.020
Biosynthesis of alkaloids derived from terpenoid and polyketide 3.066 7 51 0.028
3-Chloroacrylic acid degradation 0.361 2 6 0.046
doi:10.1371/journal.pcbi.1002223.t002
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pathway enrichment test. Promoter analysis further highlighted
adipogenic transcription factors as potential transcriptional
regulators of n-3 PUFA-correlated genes.
Supporting Information
Figure S1 Schematic illustration of pathway extraction algorithm;
data frame at right shows example network data file at each step of
algorithm. The key goal of this algorithm is to assess a linked path of
nodes (in this case ARBRCRD ) ,t oi d e n t i f yi fa nu n b r o k e np a t ho f
metabolite conversion can be traced from the first node to the last.
Given a node of interest (A) and a network path leading from A (as
determined by Djikstra’s algorithm; step 1) the algorithm examines
each reaction pair in sequence, starting with the pair linked to the
node of interest (step 2). The total list ofinteractions from ARB, and
BRC are extracted from network file (step 3). Metabolites (and
associated reactions) are removed from the pair of reactions if they
cannot be associated with a path of conversion linking reaction 1
(ARB) to reaction 2 (BRC) (step 4). Self-linked reactions are
included – e.g., BRB, where node B produces a metabolite through
interaction with A, and converts the same metabolite to a different
one that is further metabolized by node C (the algorithm only
considers a single self-linked loop within each reaction pair, if
present). If an unbroken path remains after removal of extraneous
metabolites (step 4a), reaction pair is valid and algorithm continues
to next pair of reactions (step 5). If not (step 4b), function exits.
(EPS)
Figure S2 Diet-gene and phenotype-gene relationships, and
modular partitioning mapped to the transcriptionally coordinated
human metabolic network. Green nodes: dietary variables; yellow:
lipid, fatty acid and apolipoprotein variables; red: inflammatory
and oxidative stress markers; blue: genes (enzymes). Enzyme nodes
are connected if they meet two conditions: enzyme 1 produces a
metabolite that is metabolized by enzyme 2, and genes encoding
enzymes 1 and 2 show positive coexpression in the adipose tissue
transcriptomic data. Dashed lines connecting diet-gene and
plasma marker-gene pairs indicate negative correlation. Node
shape indicates assignment in the 3 primary topological modules.
Diamond: module 1; triangle: module 2; square: module 3.
(EPS)
Table S1 Summary of anthropometric characteristics and habit-
ual dietary patterns in the LIPGENE transcriptomic study cohort.
(DOCX)
Table S2 Summary of plasma and urinary markers of metabolic
health in the LIPGENE transcriptomic study cohort.
(DOCX)
Table S3 Results from sPLS of adipose tissue gene expression
and components of recorded habitual diet. Diet-gene pairs passing
the similarity threshold of 0.7 are shown.
(DOCX)
Table S4 Results from rCCA of adipose tissue gene expression
and plasma fatty acids, lipids and apolipoproteins. Plasma marker-
gene pairs passing the similarity threshold of 0.75 are shown.
(DOCX)
Table S5 Results from rCCA of adipose tissue gene expression
and plasma cytokines, IVGTT measurements, prostaglandin and
urinary isoprostane. Plasma marker-gene pairs passing the
similarity threshold of 0.7 are shown.
(DOCX)
Figure 4. Significantly over-represented transcription factor binding sites in promoter regions of genes correlated with habitual n-
3 PUFA intake. The promoter region of each gene is depicted, with coloured boxes denoting binding site location(s) of transcription factors
displayed at right. TSS: transcription start site.
doi:10.1371/journal.pcbi.1002223.g004
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